Medical News

RSS

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

USANA Health Sciences, Inc. announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the journal Obesity and Weight Management.

26 Aug 2009

Pegasystems' business process management solution certified for full integration with Milliman Care Guidelines' CareWebQI

The Pegasystems Care Management Framework (CMF) is the first application certified as fully integrated with Milliman Care Guidelines's interactive CareWebQI((R)) clinical guideline software under a new Integration Certification program. CMF, a patient-centric business process management solution designed to improve the entire care management continuum, proved its optimum clinical workflow and usability with CareWebQI through a rigorous validation process.

26 Aug 2009

Peptimmune's Phase Ib clinical trial of PI-2301 in multiple sclerosis patients complete

Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.

26 Aug 2009

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.

26 Aug 2009

Verisk Health signs six new contracts for use of its healthcare data analytic software

Verisk Health, Inc., a global leader in healthcare data analytics, announced today signings in June and July of six new contracts for use of the Company’s healthcare analytics, clinical resource management, risk assessment, and predictive modeling software.

26 Aug 2009

Healthy San Francisco enrollees express high levels of satisfaction with city's health access program and survey shows signs of improved access to care

As states and cities struggle with the economic recession and possible fiscal pressure on public health care programs, a new Kaiser Family Foundation survey of enrollees in Healthy San Francisco (HSF), the city's health care access program for the uninsured, reports high rates of satisfaction and signs that the program has improved access to care for those uninsured residents who have enrolled.

26 Aug 2009

PD2i algorithm published in Therapeutics and Clinical Risk Management can predict risk of sudden cardiac death

David H. Fater, CEO of Vicor Technologies, Inc., today announced that original research conducted using its PD2i algorithm to prospectively predict risk of sudden cardiac death was published in Therapeutics and Clinical Risk Management.

26 Aug 2009

Studies suggest that serrated polyps can be precursors of colon cancers

Serrated colorectal polyps include the subgroups hyperplastic polyps, sessile serrated polyps (also called sessile serrated adenomas), and serrated adenomas. Recent studies have found that serrated polyps share molecular features with a subgroup of colon cancers, leading to the hypothesis that serrated polyps can be precursors of cancer through a hyperplastic polyp to serrated adenoma to cancer sequence.

26 Aug 2009

FDA to review Acorda Therapeutics’ NDA for Fampridine-SR

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company’s New Drug Application (NDA) for Fampridine-SR on October 14, 2009.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Importance of access to oral health care emphasized

Kool Smiles, a leading general dentistry provider for kids and parents, opened the doors to its newest location in the Bashford area of Louisville, KY.

26 Aug 2009

FDA recommends electronic report formats to strengthen postmarket safety data collection

The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format.

26 Aug 2009

Zargis Cardioscan software marketed along with 3M's Bluetooth-enabled Littmann electronic stethoscope

Zargis Medical Corp., a spin-off from Siemens Corporate Research (NYSE: SI) and a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that it has begun selling its Zargis Cardioscan(TM) heart sound analysis software, along with 3M's (NYSE: MMM) just-released Bluetooth(R)-enabled 3M(TM) Littmann(R) Electronic Stethoscope Model 3200, as part of its previously announced exclusive multi-year global marketing alliance with 3M.

26 Aug 2009

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.

26 Aug 2009

Defentect's radiation detection system to be installed at Washington Hospital Center

Defentect announced today Washington Hospital Center is deploying Defentect's radiation detection system hospital-wide following a pilot project to test its effectiveness, with an additional nine GT2(TM) radiation sensors and two GT4(TM) Gamma Radiation sensors, capable of isotopic identification.

26 Aug 2009

FAIR Health Plan provides cost effective healthcare to the uninsured

Nearly everyone in America can agree that the current healthcare system is broken. Now we have a real solution, the Federal Act Insurance Restructure (FAIR) Health Plan, a functional and cost-effective healthcare system. The FAIR Health Plan is designed to meet all of the strategic goals that the American people deserve. It is largely based on successful healthcare systems that are proven sustainable over the long term.

26 Aug 2009

Tikcro Technologies announces financial results for the second-quarter ended June 30, 2009

Tikcro Technologies Ltd. (OTC BB: TIKRF) today reported results for the second quarter and six months ended June 30, 2009.

26 Aug 2009

Mid-career scientists receive the 2009 Julie Martin Mid-Career Awards in Aging Research

Charleen T. Chu, MD, PhD, associate professor at the University of Pittsburgh and David M. Sabatini, MD, PhD, associate professor, Massachusetts Institute of Technology, received the 2009 Julie Martin Mid-Career Awards in Aging Research. Sponsored by The Ellison Medical Foundation, the grants provide funding of $550,000 to mid-career scientists whose research has great potential in advancing understanding of basic aging and its impact on age-related diseases.

26 Aug 2009

Positron forges Agent Agreement with Technology Imaging Services

Positron Corporation (OTCBB:POSC) (the “Company”), a molecular imaging solutions company focused on Nuclear Cardiology, announced today that they have executed an Agent Agreement with TIS – Technology Imaging Services. TIS offers a wide range of solutions for Nuclear Cardiology, Oncology, and Cardiac PET, including hot lab set up and products.

26 Aug 2009

Analysis of pending health reform bill points to huge cuts in Medicare funding

A new American Health Care Association analysis of the pending House health reform bill when combined with the impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion will result in total cuts of $44 billion over ten years.

26 Aug 2009

Medical News

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

Pegasystems' business process management solution certified for full integration with Milliman Care Guidelines' CareWebQI

Peptimmune's Phase Ib clinical trial of PI-2301 in multiple sclerosis patients complete

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Verisk Health signs six new contracts for use of its healthcare data analytic software

Healthy San Francisco enrollees express high levels of satisfaction with city's health access program and survey shows signs of improved access to care

PD2i algorithm published in Therapeutics and Clinical Risk Management can predict risk of sudden cardiac death

Studies suggest that serrated polyps can be precursors of colon cancers

FDA to review Acorda Therapeutics’ NDA for Fampridine-SR

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Importance of access to oral health care emphasized

FDA recommends electronic report formats to strengthen postmarket safety data collection

Zargis Cardioscan software marketed along with 3M's Bluetooth-enabled Littmann electronic stethoscope

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Defentect's radiation detection system to be installed at Washington Hospital Center

FAIR Health Plan provides cost effective healthcare to the uninsured

Tikcro Technologies announces financial results for the second-quarter ended June 30, 2009

Mid-career scientists receive the 2009 Julie Martin Mid-Career Awards in Aging Research

Positron forges Agent Agreement with Technology Imaging Services

Analysis of pending health reform bill points to huge cuts in Medicare funding

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News